Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,213
Closed -$225K 41
2025
Q2
$225K Sell
1,213
-288
-19% -$53.5K 0.02% 465
2025
Q1
$314K Buy
+1,501
New +$292K 0.03% 290
2024
Q4
Sell
-1,710
Closed -$338K 87
2024
Q3
$338K Sell
1,710
-124,666
-99% -$23.3M 0.02% 254
2024
Q2
$21.7M Buy
126,376
+120,819
+2,174% +$20M 0.44% 44
2024
Q1
$1.01M Buy
+5,557
New +$958K 0.06% 95
2022
Q1
Sell
-13,445
Closed -$1.82M 85
2021
Q4
$1.82M Buy
+13,445
New +$1.59M 0.04% 77

Other funds holding ABBV

MBB Public Markets's ABBV Position: Q3 2025 in Review

MBB Public Markets sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 1,213 shares — an estimated $225K sold.

MBB Public Markets first reported a position in ABBV in Q4 2021 and held it in 6 quarters. The position peaked at $21.7M in Q2 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • MBB Public Markets reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 1,213 AbbVie shares in Q3 2025, an estimated $225K.
  • MBB Public Markets first reported a position in AbbVie in Q4 2021 and held it in 6 quarters.
  • MBB Public Markets's AbbVie position peaked at $21.7M in Q2 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.